*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Development of Esomeprazole Mucoadhesive Timerx Tablets

Author: EBY GEORGE, ANJALI K BIJU, FATHIMA MEETHIAN, LINTA BENNY, SUVARNA VARGHESE
Abstract: The recent advances in the emergence of gastro retentive controlled drug delivery systems envisages the development of mucoadhesive controlled release tablets for the treatment of gastric ulcers. The present work deals with the formulation and evaluation of mucoadhesive controlled release tablets containing Esomeprazole magnesium trihydrate prepared by TIMERx technology. The blend of TIMERx polymers, Xanthan gum and Locust bean gum enhanced the duration of drug release in more controlled way. A total of six formulations namely F1,F2,F3,F4,F5 and F6 tablets were prepared by TIMERx technology containing bioadhesive polymers like Chitosan, Carbopol 974P, Polyvinyl pyrrolidone, Sodium Carboxy methyl cellulose, Sodium Alginate and Polaxomer respectively. The prepared tablets were subjected to pre and post compression evaluation studies. The flow properties were shown to be excellent for all powder blends assessed from their Carr’s Index values. F4 showed maximum hardness whereas F4 and F5 showed maximum mucoadhesion time with minimum swelling index. Considering mucoadhesion time, swelling index and mucoadhesive strength, F5 was selected and subjected to in-vitro dissolution studies and kinetic data analysis, which are then compared with the marketed controlled release tablets of Esomeprazole.F5 showed the maximum cumulative percentage release of 64.20% following zero order release kinetics, whereas marketed formulation showed a release of 36.62% after 8 hours.F5 had proved to be the best candidate considering maximum percentage drug release in controlled pattern, Mucoadhesion time and strength which are the pre-requisite properties of Esomeprazole, potentially decreasing gastric acid secretion in peptic ulcer patients.
Keyword: Sodium alginate, TIMERx, Esomeprazole, Locust bean gum, Xanthan gum
DOI: https://doi.org/10.31838/ijpr/2021.13.01.566
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free